Plasma p-tau181 levels have been shown to be strongly associated with brain tau pathology, significantly elevated in Alzheimer’s disease and differentiate the disease from other neurodegenerative disorders.10–14. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.